More articles from Volume 46, Issue 3, 2017
Randomization techniques in protocols for cluster randomized trials
Systematic review of factor validity of psychiatric scales in longitudinal studies
Comparison of clinical, biochemical and morphological parameters in patients with chronic hepatitis B
Impact of ocular comorbidities on visual function and quality of life in cataract and pseudophakic patients
Effects of different doses of zinc gluconate on antioxidative activity of metformin and glibenclamide on experimentally induced diabetes in rabbits
Morbidity of non-melanoma skin cancer
Abstract
Introduction. The incidence of both non-melanoma (NMSC) has been increasing over the past decades worldwide. The objective of the paper was to determine incidence trend of NMSC in the Serbian population on the territory of Kosovo and Metohija in the period 2004-2013. Method. Descriptive epidemiological study was done. Data about incidence for NMSC were obtained from the record. Data about population originated from International Red Cross and UMNIK. Crude incidence rates were calculated per 100 000 inhabitans. Trend lines were estimated using linear regression. Results. During a 10-year period a total number of new NMSC cases was 304 (173(56,9%) in men and 131(43,1%) in women). Аverage crude annual incidence rate was 29,08/100 000. A significantly increasing incidence trend for NMSC in men (y=0,617x+24,29, R2=0,500) was determined. Conclusion. Our findings showed significantly increasing incidence trend of NMSC. Presented findings support the important role of primary prevention and early detection of NMSC in the earliest age. Screening of skin cancers may improve treatment and prognosis by earlier diagnosis.
Keywords
References
Citation
Copyright

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Article metrics
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.